Recent News
October 8, 2024
ImmuneSensor Therapeutics Initiates Dosing in Phase 1 Clinical Trial of Lead cGAS Inhibitor Drug Candidate, IMSB301
September 17, 2024
ImmuneSensor Therapeutics Granted New U.S. Patent for its Oral cGAS Inhibitors
September 16, 2024
ImmuneSensor Therapeutics to Participate in the UBS 2024 Virtual Biotechnology Private Company Symposium
Events
UBS 2024 Virtual Biotechnology Private Company Symposium
10:30-10:55 am ET. Thursday, September 19, 2024
Tom Dubensky, Ph.D., President and CEO
In the News
September 19, 2024
DNA-Sensing Enzyme Wins the 2024 Lasker Award
September 19, 2024
Dallas scientist wins presetigious Lasker Award for immune research
September 19, 2024
Dallas scientist wins presetigious Lasker Award for immune research (video)
September 19, 2024
Zhijian “James” Chen Receives 2024 Albert Lasker Basic Medical Research Award
September 20, 2024
UT Southwestern biochemist Zhijian ‘James’ Chen, Ph.D., earns prestigious Lasker Award